1. Home
  2. ASTI vs CRVO Comparison

ASTI vs CRVO Comparison

Compare ASTI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$6.68

Market Cap

46.8M

Sector

Technology

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.90

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTI
CRVO
Founded
2005
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.8M
47.7M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
ASTI
CRVO
Price
$6.68
$3.90
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$21.50
AVG Volume (30 Days)
2.6M
88.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
69.64
N/A
EPS
N/A
N/A
Revenue
$10,398,149.00
$9,737,974.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
163.25
36.29
52 Week Low
$1.17
$1.92
52 Week High
$9.87
$16.50

Technical Indicators

Market Signals
Indicator
ASTI
CRVO
Relative Strength Index (RSI) 54.59 31.30
Support Level $1.65 N/A
Resistance Level $8.44 $5.44
Average True Range (ATR) 1.16 0.44
MACD -0.08 0.00
Stochastic Oscillator 31.78 15.74

Price Performance

Historical Comparison
ASTI
CRVO

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: